SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ribi Immunochem (ribi)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Tomko who wrote (18)1/27/1997 1:45:00 PM
From: Robert Stewart   of 92
 
Bill,

Great response and analogy regarding RIBI. Although the volume and price increases for many stocks through the January effect may be leveling off, you might want to look for the "gift horse" returns in some of the momentum stocks like GYMM, whose earnings will be out sometime after Friday. I bet the GYMM price will go up to about 3.0+ near the time of earnings announcement since the earnings will be positive for the year and for the quarter,according to their IR, will be over .15/share. Just a thought. As for myself, I think I will stick with RIBI a little longer, but not until the Jets have another winning season.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext